文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺立体定向放疗前置入水凝胶间隔物的对比研究

Hydrogel Spacer Insertion Prior to Stereotactic Body Radiation Therapy to the Prostate: A Comparative Study.
PubMed 文献 · Adv Radiat Oncol · 2025-11-22

本研究回顾性比较前列腺癌患者接受立体定向体部放疗(SBRT)时置入或不置入水凝胶间隔物的临床获益,共纳入308例患者。结果显示两组≥2级直肠毒性和2级泌尿毒性均无显著差异,且2.2%患者出现与操作相关的严重并发症。

要点

  • 水凝胶间隔物未显著降低SBRT后直肠或泌尿毒性。
  • 间隔物组操作相关严重并发症发生率为2.2%。
  • 需进一步研究选择性使用该技术的获益人群。

核心结论

  • 水凝胶间隔物置入未显著降低前列腺癌SBRT患者的直肠或泌尿毒性。

研究设计与样本

  • 回顾性检索三级医疗中心2013年6月至2018年12月间接受SBRT的前列腺癌患者数据库,比较置入与未置入水凝胶间隔物两组。

主要发现

  • 间隔物组≥2级直肠毒性为31/223(13.9%),非间隔物组为9/75(12%),差异无统计学意义。
  • 间隔物组2级泌尿毒性为58/223(26%),非间隔物组为14/75(18.6%),差异无统计学意义。
  • 限于37.5或40 Gy分5次照射的亚组分析结果相似。
  • 操作相关严重并发症发生于5/227例(2.2%)。

临床怎么用

  • 鉴于临床获益不明确且存在严重并发症风险,应选择性使用水凝胶间隔物并开展进一步研究。

局限性

  • 回顾性研究设计,样本量有限,组间剂量存在差异可能造成混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The insertion of a hydrogel spacer between the rectum and prostate before stereotactic body radiation therapy (SBRT) for prostate cancer significantly reduces the radiation dose to the rectum. Despite the widespread use of this technique, clinical data remain sparse. The objective of this study was to investigate the clinical benefit of a hydrogel spacer in SBRT. METHODS AND MATERIALS: The database of a tertiary medical center was retrospectively searched for all patients with prostate cancer who underwent SBRT, with or without the insertion of a hydrogel spacer, between June 2013 and December 2018. The groups were compared for rectal and urinary toxicity (National Cancer Institute Common Terminology Criteria for Adverse Events v4) using the χ2 test and t test. In addition, a subgroup analysis limited to patients receiving 37.5 or 40 Gy in 5 fractions was performed to account for the possible confounding effect of dose variability between the groups. Complications related to the procedure were also evaluated. RESULTS: The cohort included 308 patients who underwent SBRT with (n = 227) or without (n = 75) the insertion of a hydrogel spacer. Rates of grade 2 or higher rectal toxicity were 31 of 223 patients (13.9%) in the spacer group and 9 of 75 patients (12%) in the nonspacer group. Corresponding rates of urinary grade 2 toxicity were 58 of 223 patients (26%) and 14 of 75 patients (18.6%), respectively. Neither difference was statistically significant. Similar findings were observed in the subgroup analysis. Severe complications related to the procedure occurred in 5 of 227 cases (2.2%). CONCLUSIONS: This study did not demonstrate a significant effect of hydrogel spacer insertion on reducing rectal or urinary toxicity in patients with prostate cancer undergoing SBRT. Given the dual consideration of questionable clinical benefit and the risk of debilitating complications, additional studies should be performed on the selective use of this procedure.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Lutsyk M, Landman Y, Fenig E, et al. Hydrogel Spacer Insertion Prior to Stereotactic Body Radiation Therapy to the Prostate: A Comparative Study. Adv Radiat Oncol. 2025. PMID: 41536342. doi:10.1016/j.adro.2025.101966

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。